XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Schedule of Investments
9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Investment Holdings [Text Block]

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments

 

SEPTEMBER 30, 2025 (UNAUDITED)

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

 

TYPE OF
INVESTMENT

MATURITY DATE INTEREST RATE 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

EQX CAPITAL, INC.

                      

(7.8%)
Equipment Leasing

 

Common Stock *(1)(2)(4)

       

6/10/2016

  100,000  $20,000  $0 
  

Preferred Stock - Series A *(1)(2)(4)

     6/10/2016-

11/7/2016

  1,930,000   1,930,000   23,173 
                     23,173 
                       

INTRAOP MEDICAL CORP.

                      

(1.1%)
Medical Devices

 

Convertible Note(1)(2)(4)(6)

12/31/2025  15%  

10/11/2019

  500,000   500,000   58 
  

Convertible Note(1)(2)(4)(6)

12/31/2025

  15%  

10/22/2021

  1,000,000   1,000,000   116 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

10/29/2019

  500,000   500,000   58 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

10/6/2021

  500,000   500,000   58 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

11/12/2021

  500,000   500,000   58 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

11/29/2021

  500,000   500,000   58 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

12/31/2018

  10,961,129   10,961,129   1,270 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

2/27/2020

  1,000,000   1,000,000   116 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

2/28/2022

  200,000   200,000   23 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

3/25/2020

  500,000   500,000   58 
  Convertible Note(1)(2)(4)(6)12/31/2025  15%  

3/30/2022

  150,000   150,000   17 

 

 

See accompanying notes to financial statements

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE INTEREST RATE 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

                   
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

5/8/2020

  400,000  $400,000  $46 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

4/20/2021

  1,000,000   1,000,000   116 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

4/6/2022

  350,000   350,000   41 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

6/10/2021

  500,000   500,000   58 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

6/10/2022

  700,000   700,000   81 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

7/12/2019

  1,300,000   1,300,000   151 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

7/16/2021

  500,000   500,000   58 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

7/30/2020

  500,000   500,000   58 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

8/28/2020

  750,000   750,000   87 
 Convertible Note(1)(2)(4)(6)12/31/2025  15%

9/22/2021

  500,000   500,000   58 
 

Preferred Stock - Series C *(1)(2)(4)

     

7/12/2013

  26,856,187   26,299,939   0 
 

Term Note Matures(1)(2)(4)(6)

12/31/2025  8%

2/10/2017

  2,000,000   2,000,000   232 
 

Term Note Matures(1)(2)(4)(6)

12/31/2025  8%

2/28/2014

  3,000,000   3,000,000   348 
                  3,224 

 

 

See accompanying notes to financial statements

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

LYNCEAN TECHNOLOGIES, INC.
(0.0%)
Semiconductor Equipment

Preferred Stock - Series B *(1)(4)

7/3/2018

  869,792  $1,000,000  $0 
               

REVASUM, INC.
(0.0%)
Semiconductor Equipment

CDIs *(1)(2)(4)

11/14/2016 - 10/3/2022

  39,774,889   9,268,218   0 
               

UCT COATINGS, INC.
(57.8%)
Advanced Materials

Common Stock *(1)(3)(4)

4/18/2011

  1,500,000   662,235   171,528 
               

WRIGHTSPEED, INC.

              

(0.0%)
Automotive

Common Stock *(1)(2)(4)

6/7/2019

  69,102   7,460,851   0 
 

Preferred Stock - Series AA *(1)(2)(4)

6/7/2019 - 7/20/2020

  60,733,693   17,355,887   0 
             0 
               

INVESTMENT COMPANY
(19.9%)

Fidelity Investments Money Market Treasury Portfolio - Class I (5)

Various

  59,009   59,009   59,009 
               

TOTAL INVESTMENTS
(Cost $91,867,268)
86.6%

          256,934 

OTHER ASSETS IN EXCESS OF LIABILITIES 13.4%

          39,613 

NET ASSETS 100.0%

         $296,547 

 

All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

 

CDI:

CHESS Depositary Interests.

  

 

 

*

Non-income producing security.

(1)

Restricted security. Fair Value is determined by or under the direction of the Company's Board of Directors (see Note 3). At September 30, 2025, we held $197,925 (or 66.7% of net assets) in restricted securities (see Note 2).

(2)

Controlled investments.

(3)

Affiliated issuer.

(4)

Fair Value Level 3 security (66.7% of net assets).

(5)

The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

(6)

Security whose interest accrues until maturity however, based on September 30, 2025 valuation no such interest accrued during period ended September 30, 2025.

 

 

See accompanying notes to financial statements

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

EQX CAPITAL, INC.

                    

(2.8%)
Equipment Leasing

Common Stock *(1)(2)(4)

      

6/10/2016

  100,000  $20,000  $0 
 

Preferred Stock - Series A *(1)(2)(4)

      6/10/2016 - 11/7/2016  1,930,000   1,930,000   29,466 
                   29,466 
                     

INTRAOP MEDICAL CORP.

                    

(2.4%)
Medical Devices

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

10/11/2019

  500,000   500,000   454 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

10/22/2021

  1,000,000   1,000,000   909 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

10/29/2019

  500,000   500,000   454 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

10/6/2021

  500,000   500,000   455 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

11/12/2021

  500,000   500,000   455 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

11/29/2021

  500,000   500,000   455 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

12/31/2018

  10,961,129   10,961,129   9,966 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

2/27/2020

  1,000,000   1,000,000   909 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

2/28/2022

  200,000   200,000   182 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

3/25/2020

  500,000   500,000   455 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15% 

3/30/2022

  150,000   150,000   136 

 

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2024

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

                   
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

3/8/2020

  400,000  $400,000  $364 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

4/20/2021

  1,000,000   1,000,000   909 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

4/6/2022

  350,000   350,000   318 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

6/10/2021

  500,000   500,000   455 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

6/10/2022

  700,000   700,000   636 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

7/12/2019

  1,300,000   1,300,000   1,182 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

7/16/2021

  500,000   500,000   455 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

7/31/2020

  500,000   500,000   455 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

    

8/28/2020

  750,000   750,000   682 
 

Convertible Note (1)(2)(4)(6)

12/31/2025

  15%

9/22/2021

  500,000   500,000   455 
 

Preferred Stock - Series C *(1)(2)(4)

     

7/12/2013

  26,856,187   26,299,939   0 
 

Term Note (1)(2)(4)(6)

12/31/2025

  8%

2/10/2017

  2,000,000   2,000,000   1,818 
 

Term Note (1)(2)(4)(6)

12/31/2025

  8%

2/28/2014

  3,000,000   3,000,000   2,728 
                  25,287 

 

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2024

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

LYNCEAN TECHNOLOGIES, INC.
(0.0%)
Semiconductor Equipment

Preferred Stock - Series B *(1)(4)

     

7/3/2018

  869,792  $1,000,000  $0 
                    

REVASUM, INC.
(0.0%)
Semiconductor Equipment

CDIs *(2)(4)

     11/14/2016 - 10/3/2022  39,774,889   9,268,218   0 
                    

UCT COATINGS, INC.
(24.5%)
Advanced Materials

Common Stock *(1)(3)(4)

     

4/18/2011

  1,500,000   662,235   260,497 
                    

WRIGHTSPEED, INC.

                   

(0.0%)
Automotive

Common Stock *(1)(2)(4)

     

6/7/2019

  69,102   7,460,851   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

1/10/2023

  100,000   100,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

10/20/2021

  1,000,000   1,000,000   0 
 

Convertible Note(1)(2)(4)(6)

6/30/2025

  12%

10/21/2022

  135,000   135,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

10/23/2020

  1,050,000   1,050,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

10/5/2021

  700,000   700,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

11/11/2020

  400,000   400,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

11/14/2022

  165,000   165,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

11/23/2021

  1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

11/24/2020

  375,000   375,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

12/23/2020

  2,000,000   2,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

12/11/2020

  400,000   400,000   0 

 

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2024

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY

DATE

 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  COST BASIS  

VALUE

 

WRIGHTSPEED, INC. (continued)

                   
                    
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

12/28/2021

  1,000,000  $1,000,000  $0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

12/9/2022

  125,000   125,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

2/23/2021

  1,400,000   1,400,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

2/23/2022

  200,000   200,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

3/11/2022

  185,000   185,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

4/12/2021

  1,200,000   1,200,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

4/14/2022

  65,000   65,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

5/10/2022

  250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

5/18/2021

  1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

5/26/2022

  250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

6/10/2022

  250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

6/22/2021

  1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

6/28/2022

  250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

6/7/2019

  4,929,015   4,929,015   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

7/13/2022

  250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

7/26/2021

  1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

7/28/2022

  250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

8/12/2020

  750,000   750,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

8/12/2022

  250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

8/19/2021

  1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

9/10/2022

  900,000   900,000   0 

 

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2024

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

WRIGHTSPEED, INC. (continued)

                   
 

Convertible Note (1)(2)(4)(6)

6/30/2025

  12%

9/22/2021

  300,000  $300,000  $0 
 

Preferred Stock - Series AA *(1)(2)(4)

     6/7/2019 - 7/20/2020  60,733,693   17,355,887   0 
                  0 
                    

INVESTMENT COMPANY
(70.3%)

Fidelity Investments Money Market Treasury Portfolio - Class I (5)

     

Various

  745,224   745,224   745,224 
                    

TOTAL INVESTMENTS
(Cost $116,682,498)
100.0%

               1,060,474 

OTHER ASSETS IN EXCESS OF LIABILITIES 0.0%

               205 

NET ASSETS 100.0%

              $1,060,679 

 

 

All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

 

 

CDI:

CHESS Depositary Interests.

 

 

*

Non-income producing security.

(1)

Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (see Note 3). At December 31, 2024, we held $315,250 (or 29.7% of net assets) in restricted securities (see Note 2).

(2)

Controlled investments.

(3)

Affiliated issuer.

(4)

Fair Value Level 3 security (29.7% of net assets).

(5)

The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

(6)

Security whose interest accrues until maturity however, based on December 31, 2024 valuation no such interest accrued during period ended December 31, 2024.

 

 

See accompanying notes to financial statements